Search results for: 'areas'
- Related search terms
- areas buoyed award
- areas buoyed
- areas residuales de industries
- areas residues de industries
- areas electron bear
-
23 Oct 2020  |  North America  |  Market Research
Access to New Therapy Areas to Drive Major Growth in the Global Biosimilars Market, 2020–2026
Outsourced Manufacturing of the Complex Third Wave of Biosimilars to Spark New Growth Opportunities
In this research service, the Transformational Health team at Frost & Sullivan provides critical insights into the global biosimilar industry, highlighting the key growth opportunities, market revenue forecasts, and trends that will influence the industry with the emergence of the third wave of biosimilars. The global third-wave biosimilars market ...
$4,950.00
Special Price $3,712.50 save 25 %
-
31 Oct 2017  |  Global  |  Market Research
Global Digital Pathology Market, 2017 Companies-To-Action
Collaborative Business Models Embracing Artificial Intelligence Application in Novel Disease Areas to Drive Market Growth
It is estimated that more than 19,000 pathologists would be needed to serve the US healthcare needs. However, the actual number is expected to be approximately 40% lesser. Similar trends are foreseen globally driven by aging population and widening application in areas such as cancer diagnostics, drug development, clinical trials, biomarker discove...
$3,000.00
Special Price $2,250.00 save 25 %
-
24 Jan 2017  |  Asia Pacific  |  Market Research
Game-changing Strategies of APAC Pharma Companies
Growing Focus on Specific Therapy Areas and Shift Towards Value-based Delivery Model Expected to Boost Pharma Market
Frost & Sullivan has recently completed a comprehensive analysis on the current and future strategic imperatives of game-changing Asia-Pacific (APAC) pharmaceutical companies. The analysis primarily focuses on the changing trends in the pharmaceutical industry with respect to drug research and development, manufacturing, supply chain, and marketing...
$1,500.00
Special Price $1,125.00 save 25 %
-
25 Jul 2024  |  Global  |  Technology Research
Engineered Antibody Therapeutics for Cancer
Technology advances and increasing interest from Tier I pharmaceuticals are driving the growth of engineered antibodies
This study analyzes the emergence of engineered antibody therapeutics for cancer, examining the factors driving their adoption. The limitations of monoclonal antibodies have led to an increasing demand for novel formats. Companies are developing multispecific antibodies, such as bispecifics and trispecifics, and antibody fragments, such as Fab and ...
$4,950.00
Special Price $3,712.50 save 25 %
-
29 Dec 2015  |  Global  |  Technology Research
Collaboration between Medical Devices, Pharmaceuticals, and Biotechnology
Strategic Partnerships that are Transforming the Healthcare Industry
In an increasingly convergent industry such as healthcare, business collaborations are not only a necessity, but an inevitability. It is interesting to note that technologies and market segments that receive the most funding and research focus, are also the areas that are ripe for collaborative partnerships. Market segments such as personalized med...
$4,950.00
Special Price $3,712.50 save 25 %
-
07 Nov 2017  |  North America  |  Market Research
Growth Insights on the US Therapeutic Apheresis Market, Forecast to 2021
Product Diversification, Focus on Therapeutic Plasmapheresis and Pathogen-Reduced Platelets Will Be Key to Success
The study covers current and future market trends, drivers, challenges, and opportunities in US therapeutic apheresis market. It breaks down the market into hematology and oncology, neurology, rheumatology, and other therapeutic areas. Therapeutic apheresis has become an essential element of the blood and blood components industry value chain. Hosp...
$1,500.00
Special Price $1,125.00 save 25 %
-
27 Aug 2020  |  Global  |  Market Research
Smart Labs as Key Drivers for the Digital Transformation of Diagnostic Laboratories, 2020
Robotic Automation, Internet of Things (IoT), and Artificial Intelligence (AI) Offering Growth Opportunities for Academic and Commercial Diagnostics Labs
Diagnostic academic and commercial research labs suffer from cost pressures, given the ongoing Protecting Access to Medicare Act (PAMA) regulations and reproducibility issues, and are under productivity strain. The recent COVID-19 pandemic leading to increasing test volumes and renewed focus on research and development (R&D) to drive innovation wil...
$3,000.00
Special Price $2,250.00 save 25 %
-
23 Mar 2017  |  Asia Pacific  |  Market Research
APAC Molecular Diagnostics Market, Forecast to 2021
Pharmerging Economies with Rising Healthcare Demands will Accentuate Growth
The molecular diagnostics (MDx) market in APAC is witnessing rapid growth due to two main factors: the high adoption of MDx tests for infectious diseases applications in emerging countries, and the advent of innovative diagnostic solutions in cancer and NGS based solutions that are gaining pace in Asia. Multinational companies have not only identif...
$4,950.00
Special Price $3,712.50 save 25 %
-
13 Jan 2023  |  Global  |  Market Research
Global Life Science Instrumentation and Research Tool Growth Opportunities
Automation and Robotization to Ensure Industrywide Streamlining and Increase Future Growth Potential
New technological advances in life science instrumentation and research tools include the enhancement of next-generation sequencing (NGS) technology, digital PCR, and a wide range of informatics, robotics, and automated solutions. These improve workflow, facilitate and automate tasks, and make better use of workspaces in every area of industry. ...
$4,950.00
Special Price $3,712.50 save 25 %
-
08 Nov 2016  |  North America  |  Market Research
The US Molecular Diagnostics Market, Forecast to 2021
Polymerase Chain Reaction (PCR) Holds Close to 53% Share but Strong Clinical Research will Push NGS to Revolutionize this Space in the Next 5 to 10 Ye
The US molecular diagnostics market is growing at 12.5% CAGR and is set to reach close to $6.5 billion by 2021. PCR, next-generation sequencing (NGS), microarray, and fluorescent in situ-hybridization (FISH) are the dominant technologies in this space with PCR holding more than 75% of the market. Roche, Cepheid, Qiagen, Abbott, and Thermo Fisher do...
$4,950.00
Special Price $3,712.50 save 25 %